Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
Fallone CA, Guyatt GH, Armstrong D, Wiklund I, Degl'Innocenti A, Heels-Ansdell D, Barkun AN, Chiba N, Zanten SJ, El-Dika S, Austin P, Tanser L, Schünemann HJ. Fallone CA, et al. Among authors: tanser l. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1161-9. doi: 10.1111/j.1365-2036.2004.02257.x. Aliment Pharmacol Ther. 2004. PMID: 15569119 Free article. Clinical Trial.
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.
El-Dika S, Guyatt GH, Armstrong D, Degl'innocenti A, Wiklund I, Fallone CA, Tanser L, Veldhuyzen van Zanten S, Heels-Ansdell D, Wahlqvist P, Chiba N, Barkun AN, Austin P, Schünemann HJ. El-Dika S, et al. Among authors: tanser l. BMC Gastroenterol. 2005 Jul 10;5:23. doi: 10.1186/1471-230X-5-23. BMC Gastroenterol. 2005. PMID: 16004616 Free PMC article.
Validation of a symptom diary for patients with gastro-oesophageal reflux disease.
Puhan MA, Guyatt GH, Armstrong D, Wiklund I, Fallone CA, Heels-Ansdell D, Degl'Innocenti A, Veldhuyzen van Zanten SJ, Tanser L, Barkun AN, Chiba N, Austin P, El-Dika S, Schünemann HJ. Puhan MA, et al. Among authors: tanser l. Aliment Pharmacol Ther. 2006 Feb 15;23(4):531-41. doi: 10.1111/j.1365-2036.2006.02775.x. Aliment Pharmacol Ther. 2006. PMID: 16441474 Free article.
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease.
Schünemann HJ, Armstrong D, Degl'innocenti A, Wiklund I, Fallone CA, Tanser L, Van Zanten SV, Heels-Ansdell D, El-Dika S, Chiba N, Barkun AN, Austin P, Guyatt GH. Schünemann HJ, et al. Among authors: tanser l. Med Care. 2004 Nov;42(11):1132-42. doi: 10.1097/00005650-200411000-00013. Med Care. 2004. PMID: 15586841 Clinical Trial.
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole.
Degl' Innocenti A, Guyatt GH, Wiklund I, Heels-Ansdell D, Armstrong D, Fallone CA, Tanser L, van Zanten SV, El-Dika S, Chiba N, Barkun AN, Austin P, Schünemann HJ. Degl' Innocenti A, et al. Among authors: tanser l. Health Qual Life Outcomes. 2005 Jan 13;3:4. doi: 10.1186/1477-7525-3-4. Health Qual Life Outcomes. 2005. PMID: 15649314 Free PMC article.
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation.
Wahlqvist P, Guyatt GH, Armstrong D, Degl'innocenti A, Heels-Ansdell D, El-Dika S, Wiklund I, Fallone CA, Tanser L, Veldhuyzen van Zanten S, Austin P, Barkun AN, Chiba N, Schünemann HJ. Wahlqvist P, et al. Among authors: tanser l. Pharmacoeconomics. 2007;25(5):385-96. doi: 10.2165/00019053-200725050-00003. Pharmacoeconomics. 2007. PMID: 17488137
Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D, Veldhuyzen SJ, Chung SA, Shapiro CM, Dhillon S, Escobedo S, Chakraborty BK, Mann V, Tanser L, Nevin K. Armstrong D, et al. Among authors: tanser l. Can J Gastroenterol. 2005 Jun;19(6):350-8. doi: 10.1155/2005/569368. Can J Gastroenterol. 2005. PMID: 15997268
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Fong Y, et al. Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093/cid/ciae465. Online ahead of print. Clin Infect Dis. 2024. PMID: 39325506